Clinical and molecular characterization of familial hypocalciuric hypercalcemia in an endocrine practice: a case series of 25 patients

Read full text Summarise with VIRAT
Authors: Jack Lin, Tracy S. Wang, Amy E. Donahue, Joseph L. Shaker
Cited by: 0
References: 45

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Abstract Familial hypocalciuric hypercalcemia (FHH) is a disorder caused by abnormal sensing of calcium by the parathyroids and renal tubules and may mimic primary hyperparathyroidism (PHPT). Patients with FHH should not be subjected to unnecessary and potentially harmful parathyroid surgery. We sought to evaluate the clinical and biochemical presentation of FHH in our endocrine practice. This was a retrospective chart review done after Institutional Review Board approval. We describe 25 cases of likely FHH from our endocrine practice (20 FHH1, 1 FHH2, and 4 FHH3). The 24-h urinary calcium levels were often greater than 100 mg/24 h and sometimes greater than 200 mg/24 h. The calcium to creatinine clearance ratio (CCCR) was consistently

Fields of Study & Subjects

Parathyroid Disorders and Treatments Hormonal Regulation and Hypertension Thyroid and Parathyroid Surgery

Publication details

Journal / source
JBMR Plus
Volume
10
Issue
5
Pages
ziag049–ziag049
Publication date
24 March 2026
Language
EN